MedPath

Phenyl salicylate

Generic Name
Phenyl salicylate
Brand Names
Hyophen, Phosphasal, Urelle, Uribel, Urimar Reformulated Oct 2013, Urin DS, Ustell, Utira
Drug Type
Small Molecule
Chemical Formula
C13H10O3
CAS Number
118-55-8
Unique Ingredient Identifier
28A37T47QO

Overview

Phenyl salicylate is a 2-hydroxybenzoic acid phenyl ester. It is utilized in some manufacturing processes of polymers, lacquers, adhesives, waxes, as well as polishes. It is an active ingredient in some pharmaceutical products as a mild analgesic for pain relief by releasing salicylate (found in Aspirin ). Phenyl salicylate may also be found in some antiseptic agents . It is synthesized by heating salicylic acid with phenol , . Phenyl salicylate is used as a food additive in the USA . This compound belongs to the class of organic compounds known as depsides and depsidones. These are polycyclic compounds that is either a polyphenolic compound composed of two or more monocyclic aromatic units linked by an ester bond (depside), or a compound containing the depsidone structure (depsidone) .

Indication

Pain and fever .

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Meda Pharmaceuticals
0037-6321
ORAL
32.4 mg in 1 1
1/13/2015
Star Pharmaceuticals, LLC
0076-0111
ORAL
36 mg in 1 1
1/24/2017
A.G. Marin Pharmaceutical
12539-144
ORAL
36.2 mg in 1 1
10/7/2022
Star Pharmaceuticals LLC
0076-0903
ORAL
36 mg in 1 1
1/10/2017
Mission Pharmacal Company
0178-0745
ORAL
36.2 mg in 1 1
1/22/2024
Vilvet Pharmaceuticals Inc
71186-000
ORAL
32.4 mg in 1 1
2/21/2019
Method Pharmaceuticals, LLC
58657-456
ORAL
36 mg in 1 1
12/12/2023
Vilvet Pharmaceuticals Inc
71186-002
ORAL
36 mg in 1 1
2/21/2019
Apace Packaging, LLC
15338-503
ORAL
36 mg in 1 1
5/21/2018
Allegis Pharmaceuticals, LLC
28595-224
ORAL
36.2 mg in 1 1
7/6/2023

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
SALOL GRAN (3CH-30CH)
homeocan inc.
01952781
Tablet - Oral
3 CH / TAB
12/31/1991
WATKINS SETTELZ
watkins incorporated
00373656
Liquid - Oral
29 MG / 28.4 ML
12/31/1954
SALSOLINOL
bio active canada ltd.
02233678
Liquid - Oral
6 X
5/26/1998

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.